Literature DB >> 10522762

Behavioral interventions in the diagnosis, treatment and rehabilitation of children with cancer.

K N DuHamel1, W H Redd, S M Vickberg.   

Abstract

Behavioral interventions used to reduce distress and increase cooperation in children undergoing cancer treatment incorporate: contingency management, cognitive/attentional distraction, hypnosis, systematic desensitization, modeling and behavioral rehearsal. In most cases clinical interventions integrate these procedures into a multimodal intervention package. Although in most behavioral interventions the 'therapist' is a nurse, social worker or child psychologist; parents often take an active role in behavioral intervention. Early return to school can 'normalize' the child's life in the midst of coping with cancer and can promote optimal rehabilitation. More research is needed on the integration of behavioral methods with other therapeutic methods (e.g., pharmacologic). Indeed, research in this area of pediatric oncology must be continuously updated as advances in other areas may affect clinical decisions regarding preferred psychosocial intervention methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522762     DOI: 10.1080/028418699432879

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Chemotherapy-Induced Nausea and Vomiting.

Authors:  Karen M Mustian; Tom V Darling; Michelle C Janelsins; Pascal Jean-Pierre; Joseph A Roscoe; Gary R Morrow
Journal:  US Oncol       Date:  2008

2.  An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea.

Authors:  Joseph A Roscoe; Michael O'Neill; Pascal Jean-Pierre; Charles E Heckler; Ted J Kaptchuk; Peter Bushunow; Michelle Shayne; Alissa Huston; Raman Qazi; Brian Smith
Journal:  J Pain Symptom Manage       Date:  2010-06-25       Impact factor: 3.612

3.  Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients.

Authors:  H Oyama; M Kaneda; N Katsumata; T Akechi; M Ohsuga
Journal:  J Med Syst       Date:  2000-06       Impact factor: 4.460

4.  Movie making as a cognitive distraction for paediatric patients receiving radiotherapy treatment: qualitative interview study.

Authors:  Bradley J M Shrimpton; David J Willis; Cáthal D Tongs; Aldo G Rolfo
Journal:  BMJ Open       Date:  2013-01-16       Impact factor: 2.692

5.  A psychoeducational intervention reduces the need for anesthesia during radiotherapy for young childhood cancer patients.

Authors:  Sonja Haeberli; Michael A Grotzer; Felix K Niggli; Markus A Landolt; Claudia Linsenmeier; Roland A Ammann; Nicole Bodmer
Journal:  Radiat Oncol       Date:  2008-06-04       Impact factor: 3.481

6.  Study protocol: Rehabilitation including Social and Physical activity and Education in Children and Teenagers with Cancer (RESPECT).

Authors:  Troels Thorsteinsson; Anne Sofie Helms; Lis Adamsen; Lars Bo Andersen; Karen Vitting Andersen; Karl Bang Christensen; Henrik Hasle; Carsten Heilmann; Nete Hejgaard; Christoffer Johansen; Marianne Madsen; Svend Aage Madsen; Venka Simovska; Birgit Strange; Lone Friis Thing; Peder Skov Wehner; Kjeld Schmiegelow; Hanne Baekgaard Larsen
Journal:  BMC Cancer       Date:  2013-11-14       Impact factor: 4.430

7.  Cardiorespiratory fitness and physical function in children with cancer from diagnosis throughout treatment.

Authors:  Troels Thorsteinsson; Hanne Baekgaard Larsen; Kjeld Schmiegelow; Lone Friis Thing; Peter Krustrup; Mogens Theisen Pedersen; Karl Bang Christensen; Pernille Rudebeck Mogensen; Anne Sofie Helms; Lars Bo Andersen
Journal:  BMJ Open Sport Exerc Med       Date:  2017-05-12

8.  Pain Coping Strategies in Pediatric Patients with Acute Leukemias in the First Month of Therapy: Effects of Treatments and Implications on Procedural Analgesia.

Authors:  Marta Tremolada; Giulia Tasso; Roberta Maria Incardona; Manuela Tumino; Maria Caterina Putti; Alessandra Biffi; Marta Pillon
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.